Banco Santander (Brasil) S.A. (SANB3)
Sao Paulo Exchange · Brazil · prices in BRL · close of 15 Oct 2026
Key indicators
| Last close | BRL 14.24 |
|---|---|
| 52-week range | 11.79 – 18.02 |
| Return, 1 month / 3 months | −5.4% / +10.4% |
| Return, 1 year / 3 years | +14.0% / +42.1% |
| Trend | Below its 200-day average |
| RSI (14) | 44 |
| Volatility (1 year) | 34.8% |
| Worst drawdown (1 year) | -32.2% |
| Average daily value traded | 4.97M BRL |
| Dividend yield | 7.7% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Banco Santander (Brasil) S.A. is a bank operating in Brazil and part of the international Santander group. It serves individual customers and companies through a network of branches and digital channels, offering current and savings accounts, personal and payroll loans, credit cards, insurance, and investment and pension products, alongside corporate lending, cash management and trade finance for businesses. Its headquarters are in Sao Paulo, and it also runs consumer finance and asset management operations.
Banco Santander (Brasil) S.A. trades under the code SANB3 on the Sao Paulo Exchange in Brazil, with its price quoted in Brazilian reais (BRL). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Banco Santander (Brasil) S.A. (SANB3) trades on the Sao Paulo Exchange in Brazil. It last closed at BRL 14.24 on 15 October 2026.
Its price-based Market X-Ray is 61 out of 100 (a fair price profile), ranking 432 of 1,454 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 14.0% and over the last three months it rose 10.4%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Sao Paulo Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 48 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -1.9% | ||
| From 52-week high | -20.2% | ||
| Momentum | 57 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 10.4% | ||
| 6-month return | -6.4% | ||
| 12-month return, skipping the last month | 20.4% | ||
| Stability (higher is calmer) | 54 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 34.8% | ||
| Worst drawdown, 1 year (smaller is calmer) | -32.2% | ||
| Liquidity | 87 · Strong | Trades actively. | |
| Average daily value traded | 4.97M BRL | ||
| Zero-volume days | 0.0% | ||
| Income | 74 · Strong | Dividend is high and has been paid regularly. | |
| Dividend yield | 7.7% | ||
| Years with dividends | 6 |
Strengths
- Liquidity: Trades actively.
- Income: Dividend is high and has been paid regularly.
Weak spots
- Trend: Below its long-term averages and far from its highs.
Returns
| 1 week | −3.1% |
|---|---|
| 1 month | −5.4% |
| 3 months | +10.4% |
| 6 months | −6.4% |
| 1 year | +14.0% |
| 3 years | +42.1% |
| 5 years | – |
Signals
| 50-day / 200-day average | 14.73 / 14.51 |
|---|---|
| Golden / death cross (60 days) | Golden, 10 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.39 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 21 Jul 2026 | BRL 0.2546 |
| 20 Apr 2026 | BRL 0.2546 |
| 20 Jan 2026 | BRL 0.2552 |
| 2 Jan 2026 | BRL 0.0791 |
| 21 Oct 2025 | BRL 0.2552 |
| 17 Jul 2025 | BRL 0.2552 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Sao Paulo Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.